[
  {
    "ts": null,
    "headline": "What Do Analysts Think About Gilead Sciences (GILD)?",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable growth stocks to buy. In a report released on August 21, Evan Seigerman from BMO Capital reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD), setting a price target of $130.00. Similarly, Bernstein raised the firm’s price target on Gilead Sciences, Inc. (NASDAQ:GILD) to $135 […]",
    "url": "https://finnhub.io/api/news?id=111e71c332bb7cfe443e0073b483a77c519487c3738e5689afec0da9fde30e11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756825985,
      "headline": "What Do Analysts Think About Gilead Sciences (GILD)?",
      "id": 136611643,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable growth stocks to buy. In a report released on August 21, Evan Seigerman from BMO Capital reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD), setting a price target of $130.00. Similarly, Bernstein raised the firm’s price target on Gilead Sciences, Inc. (NASDAQ:GILD) to $135 […]",
      "url": "https://finnhub.io/api/news?id=111e71c332bb7cfe443e0073b483a77c519487c3738e5689afec0da9fde30e11"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales",
    "summary": "Gilead Sciences' (GILD) strong drug sales and upcoming clinical readouts make its stock an attractive buy despite cautious investor sentiment. Read more here.",
    "url": "https://finnhub.io/api/news?id=92da42fc29807ddc6a362a8573cdf06e759f2bbf9bca5628e505de020367ec40",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756804823,
      "headline": "Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales",
      "id": 136605968,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2218859752/image_2218859752.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences' (GILD) strong drug sales and upcoming clinical readouts make its stock an attractive buy despite cautious investor sentiment. Read more here.",
      "url": "https://finnhub.io/api/news?id=92da42fc29807ddc6a362a8573cdf06e759f2bbf9bca5628e505de020367ec40"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",
    "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Gilead Sciences, Inc. is placed seventh among them. Gilead Sciences, Inc. (NASDAQ:GILD) is making headlines with a breakthrough in HIV prevention following the FDA approval of Yeztugo, the world’s first twice-yearly preventive treatment. This milestone not only strengthens […]",
    "url": "https://finnhub.io/api/news?id=144a5eaf18da26e2ff7b4598be220afb8e2b5d9ee097c0f4c94099b9645984f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756801738,
      "headline": "Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",
      "id": 136604291,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Gilead Sciences, Inc. is placed seventh among them. Gilead Sciences, Inc. (NASDAQ:GILD) is making headlines with a breakthrough in HIV prevention following the FDA approval of Yeztugo, the world’s first twice-yearly preventive treatment. This milestone not only strengthens […]",
      "url": "https://finnhub.io/api/news?id=144a5eaf18da26e2ff7b4598be220afb8e2b5d9ee097c0f4c94099b9645984f0"
    }
  }
]